Log in
NASDAQ:NXGN

Nextgen Healthcare Price Target, Predictions & Analyst Ratings

$12.23
+0.37 (+3.12 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$11.80
Now: $12.23
$12.31
50-Day Range
$11.86
MA: $13.52
$14.81
52-Week Range
$5.10
Now: $12.23
$18.49
Volume253,075 shs
Average Volume383,102 shs
Market Capitalization$815.36 million
P/E Ratio135.89
Dividend YieldN/A
Beta1.13

Analyst Ratings

Nextgen Healthcare (NASDAQ:NXGN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
11 Wall Street analysts have issued ratings and price targets for Nextgen Healthcare in the last 12 months. Their average twelve-month price target is $12.59, predicting that the stock has a possible upside of 2.95%. The high price target for NXGN is $23.00 and the low price target for NXGN is $10.00. There are currently 1 sell rating, 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
NXGN Consensus Rating: HoldHoldHoldHold
NXGN Consensus Rating Score: 2.092.082.082.11
NXGN Analyst Ratings: 1 Sell Rating(s)
8 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
9 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
9 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
NXGN Consensus Price Target: $12.59$12.59$11.59$14.13
NXGN Price Target Upside: 2.95% upside13.88% downside12.32% upside49.95% upside

Nextgen Healthcare (NASDAQ:NXGN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Nextgen Healthcare (NASDAQ:NXGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/11/2020Morgan StanleyBoost Price TargetUnderweight$8.00 ➝ $12.00Medium
8/3/2020Deutsche BankBoost Price TargetHold$9.00 ➝ $13.00Medium
7/31/2020Wells Fargo & CompanyReiterated RatingHoldLow
7/31/2020Cantor FitzgeraldBoost Price TargetNeutral$12.00 ➝ $13.00High
7/31/2020Piper SandlerBoost Price TargetOverweight$17.00 ➝ $23.00High
5/7/2020Robert W. BairdLower Price TargetNeutral$16.00 ➝ $12.00Low
4/22/2020Jefferies Financial GroupLower Price TargetHold$14.00 ➝ $11.50High
4/20/2020Royal Bank of CanadaInitiated CoverageSector Perform$11.00Medium
4/13/2020SVB LeerinkInitiated CoverageMarket Perform$12.00High
3/26/2020SunTrust BanksLower Price TargetHold$14.00 ➝ $10.00High
3/18/2020Dougherty & CoUpgradeNeutral ➝ Buy$11.00High
8/29/2019KeyCorpUpgradeUnderweight ➝ Sector WeightMedium
(Data available from 9/27/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.